McKesson (MCK) is scheduled to announce Q2 earnings results on Wednesday, November 5th, after market close. The consensus EPS ...

McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.

The S&P 500 Index ($SPX) (SPY) on Tuesday closed down -1.17%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.53 ...

Analysts anticipate McKesson to report an earnings per share (EPS) of $9.00. McKesson bulls will hope to hear the company ...

Lifevantage (LFVN) delivered earnings and revenue surprises of +5.88% and -10.92%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

The Global Healthcare Analytics Market is poised for exponential expansion, rising from USD 42.96 billion in 2024 to USD ...